Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Beta: 1.1111 (As of Jul. 13, 2026)


SHSE:603229 Zhejiang Ausun Pharmaceutical Co Ltd SHSE:603229
83 GF Score
Price ¥8.09
GF Value ¥10.22
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Zhejiang Ausun Pharmaceutical Co Beta?

Zhejiang Ausun Pharmaceutical Co SHSE:603229 83 Beta is 1.1111 as of Jul. 13, 2026. GuruFocus rates SHSE:603229 with a GF Score™ of 83/100 and a GF Value™ of ¥10.22 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-13), Zhejiang Ausun Pharmaceutical Co's Beta is 1.1111.


Zhejiang Ausun Pharmaceutical Co  (SHSE:603229) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Zhejiang Ausun Pharmaceutical Co Beta Related Terms


Zhejiang Ausun Pharmaceutical Co Beta Historical Data

* Premium members only.

The historical data trend for Zhejiang Ausun Pharmaceutical Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Ausun Pharmaceutical Co Beta Chart

Zhejiang Ausun Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 -0.54 -0.72 0.27 1.40

Zhejiang Ausun Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 1.28 1.19 1.40 1.16

SHSE:603229 vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, Zhejiang Ausun Pharmaceutical Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Ausun Pharmaceutical Co Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang Ausun Pharmaceutical Co's Beta distribution charts can be found below:

* The bar in red indicates where Zhejiang Ausun Pharmaceutical Co's Beta falls into.


SHSE:603229
83GF Score
Zhejiang Ausun Pharmaceutical Co Ltd SHSE:603229
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Ausun Pharmaceutical Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.1111 mean?
Zhejiang Ausun Pharmaceutical Co (SHSE:603229) has a Beta of 1.1111 as of Jul. 13, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Zhejiang Ausun Pharmaceutical Co and its competitors.
Is Zhejiang Ausun Pharmaceutical Co's Beta too high?
Zhejiang Ausun Pharmaceutical Co's current Beta is 1.1111. Overall, Zhejiang Ausun Pharmaceutical Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Ausun Pharmaceutical Co's Beta compare to VRTX and REGN?
Zhejiang Ausun Pharmaceutical Co's Beta of 1.1111 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Zhejiang Ausun Pharmaceutical Co and its competitors. Zhejiang Ausun Pharmaceutical Co's current Beta is 1.1111. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Ausun Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Ausun Pharmaceutical Co (SHSE:603229) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥10.22, compared to a current price of ¥8.09 — trading 20.8% below its estimated fair value. The current Beta is 1.1111. Zhejiang Ausun Pharmaceutical Co's overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Zhejiang Ausun Pharmaceutical Co (SHSE:603229), the current Beta is 1.1111 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Ausun Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥8.09 is trading 20.8% below its estimated GF Value™ of ¥10.22. GuruFocus considers Zhejiang Ausun Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:603229:

  • Beta: 1.1111
  • GF Value™: ¥10.22 vs. price of ¥8.09 (20.8% below fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the SHSE:603229 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhejiang Ausun Pharmaceutical Co Business Description

Address No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016
Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.
83GF Score

Get the complete analysis for SHSE:603229

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.09
Price
¥10.22
GF Value